Solid Organ Transplant SHINGRIX

计划入组 2 人 · 首次发布于 2019 年 6 月 21 日

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies

计划入组 150 人 · 首次发布于 2026 年 4 月 16 日

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

计划入组 69 人 · 首次发布于 2009 年 12 月 14 日

E-137

Varicella zoster vaccine (recombinant)(Shingrix)

E2 glycoprotein inhibitors (SHAL Technologies)

Dong-E-E-Jiao Co.,Ltd.

China

BIOLOGICAL E. LIMITED

India

Biological E Limited.

United States

Dynavax's Z-1018 Shingles Vaccine Matches GSK's Shingrix Efficacy with Superior Tolerability in Phase I/II Trial

Recbio Initiates Phase III Trial of REC610 Shingles Vaccine in China

Rare Shingles Reactivation Reported Post-Shingrix Vaccination